Internal Medicine, Hematology & Oncology · Oklahoma City, OK
NPI
1700927142
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
920 Stanton L Young Blvd, Wp 2040
Oklahoma City, OK, 73104
Phone (405) 271-4022
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
1,315 services
Medicare patients, 2024
478
Average age 75
Drug cost, 2024
$4.2M
2,011 prescriptions
Company payments, 2025
$898
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kristin K Thorp was code 99215 (office e&m - established), 561 times for 115 patients. In total Kristin K Thorp billed 1,315 services in 12 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 561 | 115 | $107.04 | $60K |
| 99214 Office E&M - Established | Office | 438 | 249 | $68.95 | $30K |
| 99213 Office E&M - Established | Office | 111 | 96 | $42.52 | $4,720 |
| 99204 Office E&M - New | Office | 80 | 80 | $98.42 | $7,874 |
| 99205 Office E&M - New | Office | 54 | 54 | $131.20 | $7,085 |
| 99223 Hospital E&M - Initial | Facility | 34 | 31 | $131.48 | $4,470 |
By year: 2022 $126K for 1,522 services; 2023 $116K for 1,438 services; 2024 $117K for 1,315 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kristin K Thorp prescribed most often to Medicare patients was Anastrozole, with 297 prescriptions and refills. In total Kristin K Thorp wrote 2,011 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 297 | 718 | 82 | $10K |
| Ondansetron Hcl Generic | 89 | 91 | 48 | $689 |
| Alendronate Sodium Generic | 57 | 129 | 17 | $614 |
| Morphine Sulfate Er Morphine Sulfate | 54 | 54 | Under 11 | $1,281 |
| Hydroxyurea Generic | 51 | 119 | 12 | $1,365 |
| Prochlorperazine Maleate Generic | 51 | 51 | 34 | $970 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 43 | 43 | 15 | $875 |
| Imbruvica Ibrutinib | 42 | 42 | Under 11 | $688K |
| Dexamethasone Generic | 41 | 60 | 22 | $1,033 |
| Letrozole Generic | 40 | 112 | 16 | $1,587 |
| Gabapentin Generic | 38 | 71 | Under 11 | $1,162 |
| Potassium Chloride Generic | 37 | 65 | 15 | $395 |
| Eliquis Apixaban | 36 | 76 | Under 11 | $44K |
| Prednisone Generic | 33 | 62 | 13 | $289 |
| Morphine Sulfate Generic | 33 | 33 | Under 11 | $951 |
Brand drugs: - claims; generic drugs: 1,604 claims; opioid claims: 209.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kristin K Thorp $898 ($898 in general payments such as food, travel and fees) from 13 companies. The largest payer was Novartis Pharmaceuticals Corporation with $284.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 6 | $284 |
| Abbvie Inc. ABBV | 11 | $196 |
| Merck Sharp & Dohme LLC MRK | 3 | $78.63 |
| GlaxoSmithKline, LLC. GSK | 4 | $64.55 |
| Pfizer Inc. PFE | 2 | $37.28 |
| Astellas Pharma US Inc 4503.T | 2 | $36.81 |
| Celgene Corporation BMY | 2 | $35.73 |
| Adc Therapeutics America, Inc. | 2 | $33.2 |
| TerSera Therapeutics LLC | 1 | $32.45 |
| Lilly USA, LLC LLY | 2 | $31.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.